COMMUNIQUÉS West-GlobeNewswire

Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates
28/04/2026
Additional Detail Provided for RESTORE-FA (DT-216P2) Trial Design, Dosing and Endpoints David Shapiro, M.D., Appointed to Board of Directors, Strengthening Clinical and Regulatory Expertise Cash and Securities of $222.8 [...]
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
28/04/2026
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the [...]
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
28/04/2026
Urges Stockholders to Vote “FOR” Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today Strongly Opposes the Election of Each of DOMA’s Underqualified Nominees BRISBANE, Calif., April 28, 2026 (GLOBE NEWSWIRE [...]
Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12
28/04/2026
ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company [...]
Corza Medical Reaffirms Commitment to Gut Sutures Amid Changing Market Landscape
28/04/2026
BOULDER, Colo., April 28, 2026 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today reaffirmed its commitment to the Gut suture category, ensuring surgeons continue to have access to the [...]
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026
SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
28/04/2026
CARLSBAD, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and Chief Executive Officer, will participate in the [...]
ASAP Dental Care Sets New Benchmark in Clinical Excellence with Over 229,000 Successful Procedures Performed
28/04/2026
North Florida's Leading Dental Provider Offers an Increased Number of Procedures Across All Locations Jacksonville, FL, April 28, 2026 (GLOBE NEWSWIRE) -- ASAP Dental Care, a cornerstone of the Jacksonville healthcare [...]
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
28/04/2026
DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for [...]
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026
SAN DIEGO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, [...]
Disclosure of transparency notification from BlackRock, Inc.
28/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 28 April 2026 – 6 PM CET Disclosure of transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of [...]
FDA Announces Major Steps to Implement Real-Time Clinical Trials
28/04/2026
Agency unveils real-time trial proofs-of-concept and upcoming pilot program White Oak, Md., April 28, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two major steps as part of an [...]
EssilorLuxottica: Assemblée générale 2026 d’EssilorLuxottica
28/04/2026
Assemblée générale 2026 d’EssilorLuxottica Toutes les résolutions proposées par le Conseil d’administration adoptées Dividende de 4,00 € par action, avec possibilité de choisir un versement en actions Paris, France (28 [...]
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
28/04/2026
Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications. Company to Initiate Investigator Led Clinical Study in Pachyonychia Congenita Study Will be Led [...]
Chaque minute compte : l’EAACI appelle à une action urgente pour garantir à l’école la sécurité des enfants exposés au risque d’anaphylaxie
28/04/2026
Au Spanish Congress of Deputies (Congrès des députés espagnol), María Torres la Présidente de l’EAACI, a apporté son soutien à un manifeste commun rédigé avec l’AEPNAA, la SEAIC et la SEICAP, appelant à une action [...]
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders’ Meeting
28/04/2026
EssilorLuxottica 2026 Annual Shareholders’ Meeting All resolutions proposed by the Board of Directors adopted Dividend of Euro 4.00 per share, with option for payment in shares Paris, France (28 April 2026 – 6:00 pm [...]
Aeroflow Health Applauds Georgia Medicaid’s New Telehealth Lactation Coverage
28/04/2026
Georgia Medicaid members now have access to telehealth lactation services, following sustained advocacy efforts led by Aeroflow and the American Telemedicine Association ASHEVILLE, N.C., April 28, 2026 (GLOBE NEWSWIRE [...]
NBPure Launches Exclusive MagO7 60-Count at Walmart, Expanding Access to Its Best-Selling Gut Cleanse
28/04/2026
PHOENIX, April 28, 2026 (GLOBE NEWSWIRE) -- NBPure, a trusted leader in gut-first wellness for more than 28 years, today announced the launch of its flagship MagO7 cleanse at Walmart stores, a significant step in [...]
Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation
28/04/2026
Contribution will support multi-stakeholder efforts to strengthen the use of patient experience data in healthcare decision-making FRAMINGHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Alira Health today announced its [...]

Pages